Revenue from Q1 2011 primarily consisted of $6.5 million from sales of implants and disposables used in the 1,304 minimally invasive MAKOplasty knee procedures performed in the quarter. Additionally, approximately $5.3 million of Q1 revenue can be attributed to the sale and installation of seven RIO Robotic Arm Interactive Orthopedic systems, which is a surgical platform that supports MAKOplasty procedures.
Read the company news release about MAKO Surgical’s financial results (pdf).
Related Articles on Device Company Financial Results:
InVivo Therapeutics Reports $1.28M Net Loss in Q1
Bacterin Reports $6M in Q1 Revenue, 119% Increase
SANUWAVE Posts Q1 $252K Revenue, 76% Increase
